Rivaroxaban 20 mg (Rivaroxaban TABLET) 20 MG

Rivaroxaban 20 mg tablets are an oral anticoagulant used to prevent blood clots. This medication is commonly prescribed for conditions like deep vein thrombosis and atrial fibrillation.

Strength

20 MG

Manufacturer / TM Owner

SIVEM PHARMACEUTICALS ULC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Rivaroxaban 20 mg tablets are primarily used to reduce the risk of blood clots forming in the veins, a condition known as deep vein thrombosis (DVT). They are also used to prevent stroke in people with atrial fibrillation, a heart rhythm disorder. This medication may be prescribed for other conditions as determined by a healthcare provider.

Side Effects

Common effects of Rivaroxaban 20 mg tablets may include nausea, dizziness, and easy bruising. Some individuals might experience stomach pain or bleeding more easily than usual. It's important to report any severe or persistent side effects to a healthcare professional.

Precautions & Warnings

Rivaroxaban 20 mg tablets should be handled with care, especially if you have a history of bleeding disorders or are undergoing surgery. Always follow the guidance of a healthcare provider regarding the use of this medication. Keep the tablets out of reach of children and store them as directed.

Avoid Interactions

Rivaroxaban 20 mg tablets may interact with other medications, including certain antibiotics, antifungals, and seizure medications. Alcohol consumption should be limited, as it can increase the risk of bleeding. Always inform your healthcare provider about all medications and supplements you are taking.

Frequently Asked Questions

Rivaroxaban 20 mg tablets are used to prevent blood clots in conditions like deep vein thrombosis and to reduce the risk of stroke in atrial fibrillation.

Rivaroxaban 20 mg tablets are typically taken orally, with or without food, as directed by a healthcare provider.

Common side effects may include nausea, dizziness, and easy bruising. Severe side effects should be reported to a healthcare professional.

Rivaroxaban 20 mg may interact with certain medications, so it's important to consult a healthcare provider before combining it with other drugs.

Alcohol consumption should be limited while taking Rivaroxaban 20 mg, as it can increase the risk of bleeding.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.